Skip to main content
. 2019 Mar 5;2(4):pky082. doi: 10.1093/jncics/pky082

Table 2.

Meta-analysis results for B cell NHL overall and by HIV serostatus

All subgroups
HIV serostatus subgroups
Q Test
HIV+ HIV- Meta-regression ROR (95% CI) for HIV+ / HIV- P
Biomarker No. OR (95% CI) I2* (95% CI) Q-statistic P OR (95% CI) I2 (95% CI) OR (95% CI) I2 (95% CI)
IL-6 10 1.22 (0.97 to 1.54) 80 (65 to 89) 45.61 <.001 2.07 (1.19 to 3.60) 82 (44 to 94) 1.01 (0.97 to 1.06) 0 (0 to 69) 1.96 (1.53 to 2.50) <.001
IL-10 8 1.24 (0.93 to 1.63) 82 (65 to 90) 38.43 <.001 1.20 (0.64 to 2.24) § 1.25 (0.91 to 1.72) 84 (69 to 92) 0.96 (0.33 to 2.83) .943
TNF-α 9 1.18 (1.04 to 1.34) 63 (23 to 82) 21.46 .035 1.79 (1.35 to 2.37) 0 (– to –) 1.12 (1.02 to 1.23) 44 (0 to 76) 1.58 (1.15 to 2.18) .005
CXCL13 5 1.47 (1.03 to 2.08) 89 (78 to 95) 37.00 <.001 2.56 (1.32 to 4.96) 1.35 (0.95 to 1.92) 91 (79 to 96) 1.89 (0.69 to 5.23) .218
sCD23 4 1.57 (1.21 to 2.05) 90 (77 to 96) 29.24 <.001 1.59 (1.23 to 2.06) 0 (– to –) 1.58 (0.93 to 2.66) 0 (0 to 69) 1.00 (0.54 to 1.87) .996
sCD27 7 2.18 (1.20 to 3.98) 92 (87 to 96) 79.67 <.001 4.93 (3.00 to 8.08) 0 (– to –) 1.61 (0.89 to 2.93) 84 (69 to 92) 3.35 (1.05 to 10.71) .041
sCD30 9 1.65 (1.22 to 2.22) 90 (84 to 94) 83.01 <.001 3.69 (2.40 to 5.69) 11 (– to –) 1.40 (1.11 to 1.76) 44 (0 to 76) 2.55 (1.38 to 4.73) .003
*

Higgins’ I2 statistic measuring the proportion of the observed variance between studies relative to the total variance of a set of studies. CI = confidence interval; OR = odds ratio; ROR= ratio of odds ratios.

Q test assessing the degree to which study effect sizes are concordant.

The ratio of odd-ratios compares the odds-ratio for the HIV+ subgroup with that of the HIV- subgroup (HIV+/HIV-). The corresponding P values are computed from a test of the null hypothesis of no difference between the serostatus groups.

§

“—” and “–” denote Higgins’ I2 statistics and confidence intervals that were not calculated because of inadequate sample size, n = 1 and n = 2, respectively.